Open Ecosystem Through Secure Plug and Play Interoperability: An Overview
- PMID: 39773007
- PMCID: PMC11707763
- DOI: 10.1177/19322968241310253
Open Ecosystem Through Secure Plug and Play Interoperability: An Overview
Abstract
Background: Interoperability is a critical enabler for integrated Personalized Diabetes Management (iPDM), automated insulin delivery (AID), and the digital transformation of healthcare in general. However, manufacturers still create closed ecosystems (ie, solutions designed to work end-to-end minimizing collaboration with other organizations) with proprietary interfaces because of various interoperability challenges. Therefore, the aim of this article is to provide an overview of how to achieve organizational interoperability in an open ecosystem (ie, solutions designed to integrate different organizations via interoperability standards) for diabetes management.
Methods: The proposed interoperability design approach called Secure Plug and Play Interoperability (SPPI) supports building and using interoperable system elements in an open ecosystem. Secure Plug and Play Interoperability enables interoperability over the entire system life cycle with its reference architecture, secure interoperability standards, and organizational capabilities. These standards were developed with participation from healthcare providers, regulatory authorities, payers, academia, and manufacturers. Publicly available information provides examples of implementation support and practical usage.
Results: Organizational interoperability in an open ecosystem can be achieved through organizational capabilities and a selection of secure interoperability standards. ISO/IEEE 11073, Bluetooth profiles, and HL7 FHIR with test specifications, test tools, software development kits, and quality assurance programs represent a coordinated selection suitable for building an open ecosystem. Practical usage is demonstrated with real-world solutions that build on these standards.
Conclusions: Secure Plug and Play Interoperability facilitates the end-to-end integration of devices, digital products, and services from partners in an open ecosystem. Moreover, even a single manufacturer, who provides all system elements of a solution, can use and benefit from SPPI.
Keywords: automated insulin delivery; cybersecurity; integrated personalized diabetes management; privacy; reference architecture; standards.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Christoph Fischer is an employee of Roche Diabetes Care GmbH.
Figures





Similar articles
-
The Conceptual Modeling of Interoperability Framework of Heart Sound Monitor in the Context of an Interoperable End-to-End Architecture.Telemed J E Health. 2019 Sep;25(9):808-820. doi: 10.1089/tmj.2018.0188. Epub 2018 Oct 17. Telemed J E Health. 2019. PMID: 30328780 Review.
-
Designing Interoperable Health Care Services Based on Fast Healthcare Interoperability Resources: Literature Review.JMIR Med Inform. 2023 Aug 21;11:e44842. doi: 10.2196/44842. JMIR Med Inform. 2023. PMID: 37603388 Free PMC article. Review.
-
HL7 Fast Healthcare Interoperability Resources (HL7 FHIR) in digital healthcare ecosystems for chronic disease management: Scoping review.Int J Med Inform. 2024 Sep;189:105507. doi: 10.1016/j.ijmedinf.2024.105507. Epub 2024 Jun 4. Int J Med Inform. 2024. PMID: 38870885
-
A mobile health monitoring-and-treatment system based on integration of the SSN sensor ontology and the HL7 FHIR standard.BMC Med Inform Decis Mak. 2019 May 10;19(1):97. doi: 10.1186/s12911-019-0806-z. BMC Med Inform Decis Mak. 2019. PMID: 31077222 Free PMC article.
-
Towards a comprehensive and interoperable representation of consent-based data usage permissions in the German medical informatics initiative.BMC Med Inform Decis Mak. 2020 Jun 5;20(1):103. doi: 10.1186/s12911-020-01138-6. BMC Med Inform Decis Mak. 2020. PMID: 32503529 Free PMC article.
Cited by
-
Digital Therapeutics for Cognitive Impairment: Exploring Innovations, Challenges, and Future Prospects.J Med Internet Res. 2025 Jun 12;27:e73689. doi: 10.2196/73689. J Med Internet Res. 2025. PMID: 40504630 Free PMC article.
References
-
- Magliano DJ, Boyko EJ. IDF Diabetes Atlas 10th Edition Scientific Committee (IDF Diabetes Atlas 2021 [online]). 10th ed. Brussels, Belgium: International Diabetes Federation; 2021. https://diabetesatlas.org/atlas/tenth-edition. Accessed July 18, 2024.
-
- World Health Organization (WHO). Fact sheet: the top 10 causes of death [online]. 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed July 18, 2024.
-
- American Diabetes Association (ADA). Standards of care in diabetes—2024 [online]. 2023. https://diabetesjournals.org/care/issue/47/Supplement_1. Accessed August 4, 2024.
-
- Kulzer B, Daenschel W, Daenschel I, et al.. Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: results of the PDM-ProValue study program. Diabetes Res Clin Pract. 2018;144:200-212. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical